Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.054 | 0.8 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.049 | 0.8 |